Document is current
Any future updates will be listed below
-
Authors
Terada, Tatsuhiro
Yokokura, Masamichi
Obi, Tomokazu
Bunai, Tomoyasu
Yoshikawa, Etsuji
Ando, Ichiro
Shimada, Hitoshi
Suhara, Tetsuya
Higuchi, Makoto
Ouchi, Yasuomi
-
Funding
Funding for this research was provided by:
Japanese Ministry of Education, Culture, Sports, Science and Technology (16H06402A01, 17H042470001)
Japan Agency for Medical Research and Development (16768966)
Grant-in-Aid for Research and Development Grants for Dementia (16768966)
- License Information
-
More Information
Article History
Received: 4 April 2019
Revised: 21 May 2019
Accepted: 23 May 2019
First Online: 28 May 2019
Compliance with ethical standards
:
: Authors TT, MY, TO, TB, EY, IA and YO declare no competing interests. HS, TS and MH hold patent on compounds related to the present report (JP 5422782/EP 12 884 742.3), and the National Institutes for Quantum and Radiological Science and Technology made a license agreement with APRINOIA Therapeutics Inc. regarding this patent.
